Leerink raises AstraZeneca stock price target to $220 on COPD drug data
Corroborated by 1 source from 1 publisher
ushealth2h ago
TL;DR
Leerink raises AstraZeneca stock price target to $220 on COPD drug data.
Sources
1
Investing.com News
https://www.investing.com/news/analyst-ratings/leerink-raises-rocket-pharmaceuticals-stock-price-target-on-fda-approval-93CH-4585831
3h ago
2
Investing.com News
https://www.investing.com/news/analyst-ratings/leerink-raises-astrazeneca-stock-price-target-to-220-on-copd-drug-data-93CH-4586114
2h ago